Bookmark and Share

This article is in the news archive.

4 year funded PhD available in Strathclyde Institute of Pharmacy & Biomedical Sciences

A 4 year fully funded BBSRC PhD Case Studentship with AstraZeneca is available at the Strathclyde Institute of Pharmacy & Biomedical Sciences titled ‘Interrogating the cortico-striatal-thalamo-cortical circuitry: implications for neuropsychiatric drug discovery’. The successful candidate will employ new optogenetic techniques combined with in vivo electrophysiological recordings and neuroimaging in genetically modified mice.  These technologies are at the leading edge of Neuroscience and will provide comprehensive skills and training to students embarking on a career in biomedical research/drug discovery.

The project will be jointly supervised by Professor Judith Pratt, Professor Brian Morris (, Dr Shuzo Sakata and Dr Nick Brandon (AstraZeneca). More information regarding the studentship and the online application process can be found at (

The Strathclyde Institute of Pharmacy and Biomedical Sciences is a major research centre that has a thriving postgraduate community with around 150 students originating from all corners of the globe.  Our students benefits from world-class facilities including the recent opening of the new £36M state-of-the-art building in the centre of Glasgow and a significant investment in core research facilities.  Further details of the research activity within SIPBS can be found at

Applicants should have or will expect to attain at least a 2i degree classification in Neuroscience, Pharmacology, Physiology or a related discipline. This studentship is available to UK and other EU nationals (due to funding criteria, EU nationals MUST have resided in the UK for three years prior to commencing the studentship). 

Start date is 1st October 2013 and the closing date for application is 25th February 2013. Please direct all informal enquiries to Professor Judith Pratt ( Tel 00 44 (0) 141 548 2123

Posted on 30/01/2013

Further news

Go to the news index page.